Basics Beam Therapeutics Inc. IPO Date: February 6, 2020 Sector: Healthcare Industry: Biotech Market Cap: $1.97B Activated in VL: True Average Daily Range Avg Daily Range: $1.57 | 3.48% Avg Daily Range (30 D): $0.49 | 2.62% Avg Daily Range (90 D): $0.61 | 3.24% Institutional Daily Volume Avg Daily Volume: .9M Avg Daily Volume (30 D): 1.88M Avg Daily Volume (90 D): 1.96M Trade Size Avg Trade Size (Sh.): 58 Avg Trade Size (Sh.) (30 D): 73 Avg Trade Size (Sh.) (90 D): 72 Institutional Trades Total Inst.Trades: 3,014 Avg Inst. Trade: $3.13M Avg Inst. Trade (30 D): $2.58M Avg Inst. Trade (90 D): $2.75M Avg Inst. Trade Volume: .08M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $4.85M Avg Closing Trade (30 D): $4.43M Avg Closing Trade (90 D): $4.48M Avg Closing Volume: 133.13K     News Jun 28, 2025 @ 1:10 PM 10 Under-the-Radar Healthcare Stocks With Incredib... Source: Dan Victor Jun 17, 2025 @ 2:07 PM Editas Medicine Is Great. Here's Why You Shouldn't... Source: Dan Victor May 29, 2025 @ 8:01 PM Beam Therapeutics Announces U.S. FDA Orphan Drug D... Source: N/A May 6, 2025 @ 9:05 PM Why Beam Therapeutics Stock Tanked on Tuesday Source: Eric Volkman Mar 10, 2025 @ 10:01 AM Beam Therapeutics Announces Pricing of Underwritte... Source: N/A Financials   TTM Q1 2025 Q4 2024 Basic EPS $-4.61 $-1.24 $-1.09 Diluted EPS $-4.61 $-1.24 $-1.09 Revenue $ 63.58M $ 7.47M $ 30.07M Gross Profit $ $ $ Net Income / Loss $ -387.34M $ -109.27M $ -90.35M Operating Income / Loss $ -430.72M $ -119.29M $ -100.04M Cost of Revenue $ $ $ Net Cash Flow $ 240.22M $ 244.41M $ 53.36M PE Ratio